Forum Bioscience Holdings Overview
- Founded
-
1980

- Status
-
Acquired/Merged
- Employees
-
2

- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Forum Bioscience Holdings General Information
Description
Supplier of pharmaceuticals. The company's pharmaceutical portfolio consist of active and supplementary ingredients in the area of veterinary medicine and APO-go, an active ingredient apomorphine, for the treatment of Parkinson's disease, enabling customers to receive the necessary medicines.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 41-51 Brighton Road
- Redhill RH1 6YS
- England, United Kingdom
Forum Bioscience Holdings Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Forum Bioscience Holdings Patents
Forum Bioscience Holdings Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-0520149-D0 | Wound healing compositions | Inactive | 04-Oct-2005 | ||
GB-0517044-D0 | Virucidal solutions | Inactive | 19-Aug-2005 | 000000000 | |
GB-2429152-A | Electrochemically activated water for use as a virucide | Inactive | 19-Aug-2005 | 000000000 | 0 |
EP-1740226-A1 | Disinfectant solutions | Inactive | 01-Apr-2004 | 000000000 | |
US-20070243597-A1 | Disinfectant solutions | Inactive | 01-Apr-2004 | A61L2/186 |
Forum Bioscience Holdings Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Peter Duckworth | Managing Director & Co-Founder |
Forum Bioscience Holdings Signals
Forum Bioscience Holdings Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|